Discounting health gain: a different view
- PMID: 37937314
- PMCID: PMC10627044
- DOI: 10.1080/20016689.2023.2275350
Discounting health gain: a different view
Abstract
At least since the Age of Enlightenment, good health has been a tenet for society. Healthy societies could learn better, work harder, improve their wealth, and live longer. Today societies focus on life expectancy, as we value long and healthy lives. As illustrated by the provision of COVID-19 vaccines first for the elderly, societies value life-saving actions. Paradoxically, health economic assessments conventionally devalue long-lasting health through the practice of discounting health benefits along with costs. However, health, with its intrinsic and instrumental characteristics, is not synonymous with money cash, a tradeable asset that devalues with time. If improving healthy life expectancy is a societal ambition, it seems counter-intuitive to value future health less as a result of an artificial mathematical construct when evaluating economically new medical interventions. In this paper, we investigate the application of discounting health in healthcare and consider paradoxical findings, especially in relation to disease prevention with vaccination. We argue that there is no economically sustainable argument to discount health gains, except for the benefit of the payer with a goal of spending less on life-saving products. If that is the objective for discounting health, there are other means to achieve the same goal in a more transparent and simpler way. From the long-term perspective of healthcare development, not discounting health gains would encourage research that values long-term effects. This in turn has the potential to benefit the investor, the payer, and the patient/consumer, improving the situation from multiple perspectives.
Keywords: Discounting; economic assessment; health; vaccination.
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the auhtors related to this work.
Figures






Similar articles
-
How Should NICE Assess Future Costs and Health Benefits? [Internet].London: National Institute for Health and Care Excellence (NICE); 2011 Nov 4. Citizens Council Reports No. 15. London: National Institute for Health and Care Excellence (NICE); 2011 Nov 4. Citizens Council Reports No. 15. PMID: 28230942 Free Books & Documents. Review.
-
Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.Geriatr Gerontol Int. 2021 Aug;21(8):601-613. doi: 10.1111/ggi.14201. Epub 2021 Jul 1. Geriatr Gerontol Int. 2021. PMID: 34212470
-
Critical reflections on the currently leading definition of sustainable employability.Scand J Work Environ Health. 2016 Jun 1;42(6):557-560. doi: 10.5271/sjweh.3585. Epub 2016 Aug 22. Scand J Work Environ Health. 2016. PMID: 27548816
-
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy.Pharmacoeconomics. 2005;23(8):791-802. doi: 10.2165/00019053-200523080-00005. Pharmacoeconomics. 2005. PMID: 16097841
-
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.Vaccine. 2022 Jun 26;40(30):4008-4016. doi: 10.1016/j.vaccine.2022.04.050. Epub 2022 May 23. Vaccine. 2022. PMID: 35618559 Review.
References
-
- Greaves HRG. Discounting Future Health. Global Health Priority-Setting. 2019. https://api.semanticscholar.org/CorpusID:213387127
LinkOut - more resources
Full Text Sources
Research Materials